Insiders · CRXT

CRXT insider transactions

Clarus Therapeutics Holdings Inc. (CRXT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CRXT

• 1416d
  SEC Form 4: Prygocki Mark A Sr was granted 1,922 shares, increasing direct ownership by 50% to 5,766 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1416d
  SEC Form 4: Murphy Kimberly M was granted 1,922 shares, increasing direct ownership by 50% to 5,766 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1416d
  SEC Form 4: Amory John Kenneth was granted 1,922 shares, increasing direct ownership by 50% to 5,766 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1416d
  SEC Form 4: Hernandez Joseph was granted 1,922 shares, increasing direct ownership by 0.15% to 1,243,266 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1416d
  SEC Form 4: Cermak Elizabeth was granted 1,922 shares, increasing direct ownership by 50% to 5,766 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1459d
  SEC Form 4: Hernandez Joseph acquired 1,237,500 shares and disposed of 65,000 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1461d
  SEC Form 4: Thomas Mcnerney & Partners Lp sold $9,494,867 worth of shares (3,752,912 units at $2.53) (Amendment)

  4/A - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Prygocki Mark A Sr was granted 3,844 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Jaeger Frank was granted 29,000 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Cermak Elizabeth was granted 3,844 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Amory John Kenneth was granted 3,844 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Hernandez Joseph was granted 3,844 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Dudley Robert E. was granted 135,000 shares, increasing direct ownership by 2,957% to 139,566 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Bourne Steven A. was granted 29,000 shares, increasing direct ownership by 2,222% to 30,305 units

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Peterson Richard D was granted 55,800 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)
• 1593d
  SEC Form 4: Murphy Kimberly M was granted 3,844 shares

  4 - Clarus Therapeutics Holdings, Inc. (0001817944) (Issuer)